The mouse dystrophin muscle enhancer-1 imparts skeletal muscle, but not cardiac muscle, expression onto the dystrophin Purkinje promoter in transgenic mice

Human Molecular Genetics
Yves De RepentignyRashmi Kothary

Abstract

A subset of patients harboring mutations in the dystrophin gene suffer from X-linked dilated cardiomyopathy (XLCM), a familial heart disease that is not accompanied by any clinical signs of skeletal muscle myopathy. As the muscle (M) isoform of dystrophin is not expressed in these patients, the absence of skeletal muscle symptoms has been attributed to expression of the brain (B) and cerebellar Purkinje (CP) isoforms of dystrophin in skeletal, but not cardiac, muscles of XLCM patients. The compensatory mechanism of dystrophin B and CP promoter upregulation is not known but it has been suggested that the dystrophin muscle enhancer from intron 1, DME-1, may be important in this activity. Previous studies have shown that the presence of the DME-1 is essential for a significant increase in dystrophin B and CP promoter activity in skeletal muscle cells in culture. Here, we demonstrate that the mouse dystrophin CP promoter drives expression of a lacZ reporter gene specifically to the cerebellar Purkinje cell layer but not to skeletal or cardiac muscle of transgenic mice. However, if the mouse counterpart of DME-1 is present in the transgene construct, the dystrophin CP promoter is now activated in skeletal muscle, but not in cardiac ...Continue Reading

References

Feb 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·F M BoyceL M Kunkel
May 7, 1987·The New England Journal of Medicine·B A Berko, M Swift
Aug 1, 1995·The Journal of Clinical Investigation·F MuntoniC Sewry
Jul 1, 1993·Neuromuscular Disorders : NMD·A E Emery
Jan 1, 1996·Brain Pathology·H M Sadoulet-Puccio, L M Kunkel
Dec 5, 1998·The Journal of Biological Chemistry·F GalvagniS Oliviero
May 2, 2002·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Philip MarshallRonald G Worton
Aug 23, 2002·Differentiation; Research in Biological Diversity·Céline Boudreau-Larivière, Rashmi Kothary

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.